In terms of demand, orphan drugs (pharmaceuticals for rare medical conditions) do not constitute a large share of the ethical drug market. However, since there are patients suffering from these disorders, there is a need for pharmaceutical companies to develop and deliver drugs for such patients. Ohara Pharmaceutical is involved in research and development as well as the manufacture and distribution of many orphan drugs, including anti-cancer drugs, medications to treat leukemia, antiparkinson agents, and drugs for irritable bowel syndrome (IBD).
We will continue in our endeavors as a company that cares for individual patients by actively incorporating technology from areas where rapid advancement is expected in the future. These include antibody medicine, regenerative medicine and genetically modified pharmaceuticals.